Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017949 · ClinicalTrials.gov registry record
Do Knee Injections Offer Benefit With Knee Arthritis Pain
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 75
- Enrollment target
NCT04017949 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 75 participants.
The verdict
NCT04017949 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Corticosteroid and viscosupplementation injections have been used for years to treat osteoarthritic pain in knees. Recent studies have varied in reporting the effectiveness with these injections. None have been found to analyze pain scores between the groups though. This study aims to evaluate the effectiveness of corticosteroid injection (a single injection of 1 cc of 40 mg kenalog: 4 cc 0.5% Naropin) and viscosupplementation injection (Euflexxa and Synvisc, both are 2 cc of the medication given in 3 injections over a 3 week period). This will be analyzed with a modified visual analog scale over a period of time. An initial VAS will be collected prior to the first injection in the clinic. With the viscosupplementation injections, a VAS will be collected prior to injections 2 and 3 as well. These VAS are logged in the patient's chart. For both types of injections, the participant will be called and a VAS will be recorded 6 weeks post injection and 3 month post injection. These VAS will NOT be logged in the participant's chart. All VAS will be collected/recorded by the principal investigator. Statistical analysis will be conducted with a paired t-test (p\<0.05 with a confidence interval at 95%) from the pre-injection VAS and VAS subsequently.
Interventions
- DRUG Corticosteroid injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2019-08-21 |
| Est. Completion | 2020-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04017949
The ClinicalTrials.gov registry entry for NCT04017949 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corticosteroid injection is the first listed.
NCT04017949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04017949 about?
NCT04017949 is a clinical study titled "Do Knee Injections Offer Benefit With Knee Arthritis Pain". Corticosteroid and viscosupplementation injections have been used for years to treat osteoarthritic pain in knees. Recent studies have varied in reporting the effectiveness with these injections. None have been found to analyze pain scores between the groups though. This study aims to evaluate the ...
What is the current status of trial NCT04017949?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2019-08-21. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT04017949?
The interventions under investigation include: Corticosteroid injection (DRUG).
Who is sponsoring clinical trial NCT04017949?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.